首页 | 本学科首页   官方微博 | 高级检索  
     


North Central Cancer Treatment Group Phase I Trial N057K of Everolimus (RAD001) and Temozolomide in Combination With Radiation Therapy in Patients With Newly Diagnosed Glioblastoma Multiforme
Authors:Jann N. Sarkaria  Evanthia Galanis  Wenting Wu  Patrick J. Peller  Caterina Giannini  Paul D. Brown  Joon H. Uhm  Steven McGraw  Kurt A. Jaeckle  Jan C. Buckner
Affiliation: Mayo Clinic Rochester, Rochester, MN
Sioux Community Cancer Consortium, Sioux Falls, SD
Mayo Clinic Florida, Jacksonville, FL
Abstract:
Keywords:Glioblastoma   Radiation   Temozolomide   Fluorodeoxyglucose positron emission tomography   Everolimus
本文献已被 ScienceDirect 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号